Algeta for investors
Algeta aims to be an attractive investment for its shareholders through consistent performance and information.
-
Presentation of the second quarter report
28 Aug 2013
-
Presentation of the third quarter report
6 Nov 2013
Corporate strategy
Algeta’s strategy is to build a commercial operation as well as expand its portfolio of oncology product candidates.
Contact us
If you'd like to know more about Algeta and our research, please do get in touch – we'd love to hear from you.